RHÖN-KLINIKUM AG reports 6.8% revenue growth despite profit dip in 2025

RHÖN-KLINIKUM AG has reported its financial results for 2025, showing steady growth despite some challenges. The healthcare group, which runs five major clinics across Germany, increased its revenue while expanding patient care and investing in new technology. The company's consolidated revenue rose by 6.8% in 2025, reaching €1,704.7 million. This growth came alongside a 2.5% rise in patient numbers, with 938,650 people treated across its facilities. However, profits fell to €36.3 million, largely due to higher depreciation costs and lower interest rates.

During the year, RHÖN-KLINIKUM AG introduced new medical services at all its locations. One key development was the adoption of photon counting computer tomography, making it the only hospital group in Germany with three of these advanced systems in operation. Dr. Stefan Stranz, a company executive, credited the group's stable performance to its partnership with ASKLEPIOS.

Looking ahead, the company expects revenue of around €1.7 billion for 2026, with a possible variation of plus or minus 5%. Its earnings before interest, taxes, depreciation, and amortisation (EBITDA) are forecast to land between €110 million and €125 million, following a 2025 figure of €105.9 million. Shareholders will receive a proposed dividend of €0.20 per share, as agreed by the Supervisory Board and Board of Management. RHÖN-KLINIKUM AG continues to expand its healthcare services while navigating financial pressures. With new technology in place and steady patient growth, the group remains focused on maintaining its position in the German medical sector. The dividend proposal reflects a balanced approach to rewarding investors while funding future development.